Sensona, Inc.
Zoya A. Cheglakov is a highly accomplished professional in the field of molecular biology and chemistry, currently serving as the CEO, President, and cofounder of Sensona, Inc. since August 2017, where also holds the title of Chief Scientific Officer. Prior to this, Zoya A. Cheglakov was a Postdoctoral Researcher at The University of Chicago from June 2014 to June 2018. Zoya A. Cheglakov earned a PhD in Molecular Biology from the University of Chicago, completed a Master's Degree in the Chemistry of Biomaterials at the Hebrew University of Jerusalem, and holds a Bachelor's Degree in Chemistry from the same institution.
This person is not in any teams
Sensona, Inc.
Sensona's technology delivers portable, 8-minute diagnostic tests using a novel approach based on the exclusive, internal heating system activated by Infra-Red-light sensitive nanoparticles. The unique nanoparticles were invented, synthesized, and purified by Sensona's R&D team. Our technology was recently granted the U.S. patent and several international patents, which provide us exclusive rights to manufacture and use the nanoparticles for the PCR, RT-PCR, qPCR, and other Nucleic Acid Amplification methods. Our portable, ultrafast, compact, and highly affordable system is the ultimate solution for detecting and rapidly diagnosing contagious outbreaks and provides a powerful tool to slow down the antibiotic-resistance threat. The future is here, and our first challenge is to give a serious fight against SARS-CoV-2. COVID-19 portable, rapid diagnostic tests at schools, airports, ambulances, army bases, shopping centers, and many other possibilities are not a dream anymore. The future is here! It's not magic; it's science!